消异方联合腹针治疗子宫腺肌症临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R711.74

基金项目:


Clinical Study on Xiaoyi Prescription Combined with Abdominal Acupuncture for Adenomyosis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察消异方联合腹针治疗子宫腺肌症(AM) 的临床疗效及对患者月经量、痛经程度、子宫内膜容受性及程序性死亡因子配体1(PD-L1) 表达的影响。方法:选取104例AM患者,按随机数字表法分为腹针组和针药组各52例。针药组给予消异方联合腹针治疗,腹针组单纯给予腹针治疗,连续治疗3个月经周期。比较2组治疗前后的月经量、痛经评分、子宫内膜容受性和PD-L1表达情况,评价疗效,观察不良反应发生情况。结果:治疗后,2组月经失血图评分法(PBAC) 评分、痛经评分均较治疗前降低(P<0.05),子宫体积均较治疗前缩小(P<0.05);针药组PBAC评分、痛经评分下降幅度及子宫体积的缩小幅度均大于对照组(P<0.05)。治疗后,2组子宫内膜胞饮突数量丰富率及成熟率均较治疗前提高(P<0.05),针药组子宫内膜胞饮突数量丰富率及成熟率均高于腹针组(P<0.05)。治疗后,2组PD-L1表达评分均较治疗前降低(P<0.05),腹针组PD-L1表达评分低于对照组(P<0.05)。针药组治疗总有效率为94.23%,高于腹针组的76.92%(P<0.05)。治疗期间,2组均未见明显不良反应。结论:消异方联合腹针治疗AM疗效肯定,可有效缓解患者的痛经症状,减少月经量,缩小子宫体积,降低异位病灶PD-L1表达,改善子宫内膜容受性。

    Abstract:

    enomyosis(AM) and its effect on the menstrual amount, the degree of dysmenorrhea, endometrial receptivity and the expression of programmed death ligand- 1(PD- L1). Methods:A total of 104 cases of patients with AM were selected and divided into the abdominal acupuncture group and the acupuncture and medication group according to the random number table method,52 cases in each group. The acupuncture and medication group was given Xiaoyi prescription combined with abdominal acupuncture,and the abdominal acupuncture group was given simple abdominal acupuncture. Both groups were continuously treated for three menstrual cycles. The menstrual amount,the scores of dysmenorrhea,endometrial receptivity and the expression of PD- L1 before and after treatment in the two groups were compared, and the curative effect was evaluated. The incidence of adverse reactions was observed. Results: After treatment, compared with those before treatment, the scores of Pictorial Blood loss Assessment Chart(PBAC) and dysmenorrhea in the two groups were decreased (P<0.05),and the uterine volumes were shrunk(P<0.05);in the acupuncture and medication group,the decrease of the scores of PABC and dysmenorrhea and the shrinkage of the uterine volume were larger than those in the control group(P<0.05). After treatment, the richness and the maturation rate of endometrial pinopodes in the two groups were increased when compared with those before treatment(P<0.05),and the above two indexes in the acupuncture and medication group were higher than those in the abdominal acupuncture group(P<0.05). After treatment, the scores of the expression of PDL1 in the two groups were decreased when compared with those before treatment(P<0.05), and the above score in the abdominal acupuncture group was lower than that in the control group(P<0.05). The total effective rate was 94.23% in the acupuncture and medication group, higher than that of 76.92% in the abdominal acupuncture group(P<0.05). During treatment, no significant adverse reactions occurred in the two groups. Conclusion: The therapy of Xiaoyi prescription combined with abdominal acupuncture has significant curative effect in treating AM, which can effectively alleviate the symptoms of dysmenorrhea,reduce the menstrual amount, shrink the uterine volume,as well as decrease the expression of PD-L1 in ectopic focus and improve endometrial receptivity.

    参考文献
    相似文献
    引证文献
引用本文

李慰,李兴花,严春红,丛玲华.消异方联合腹针治疗子宫腺肌症临床研究[J].新中医,2020,52(11):69-72

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2020-06-04
  • 出版日期:
文章二维码